Publications by authors named "Paula Luque"

Article Synopsis
  • - The study evaluates the effectiveness and safety of adalimumab in treating non-infectious uveitis across four Spanish hospitals from 2012 to 2022, analyzing patient data on relapses, inflammation, and medication dosage changes.
  • - Out of 122 patients, most were middle-aged Caucasian women with refractory uveitis; results showed significant reductions in both relapses and corticosteroid use, along with improved visual acuity.
  • - Overall, adalimumab demonstrated high efficacy and safety in managing non-infectious uveitis, with minimal serious side effects and a low incidence of anti-drug antibody development.
View Article and Find Full Text PDF

Background: Sacubitril/valsartan (an Angiotensin receptor-neprilysin inhibitor-ARNI) is one of the cornerstones in the management of patients with heart failure with reduced ejection fraction (HFrEF) having demonstrated significant reductions in both mortality and hospitalisations as compared with enalapril. It proved to be a cost-effective treatment in many countries with stable economies. In Argentina, a country with chronic financial instability and a fragmented health care system, the estimation of its cost-effectiveness requires to consider local financial data.

View Article and Find Full Text PDF